Craft

Biological E

Revenue

₹9.3 B

FY, 2019

Biological E Summary

Company Summary

Overview
Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines. It operates 4 strategic business units: Branded Formulations, Speciality Generic Injectables, Synthetic Biology, and Vaccines and Biologics. The Branded Formulations unit supplies Heparin and Noscapine-based cough medications. The Speciality Generic Injectables unit develops and commercializes injectable products, primarily non-biological complex drugs, as well as complex and routine injectable products. The Synthetic Biology unit is focused on making active pharmaceutical ingredients (APIs) using synthetic biology. The Vaccines and Biologics unit produces Tetanus, Pentavalent, Polyvalent Snake Antivenom, and other vaccines.
Type
Private
Status
Active
Founded
1953
HQ
Hyderabad, IN | view all locations
Website
https://www.biologicale.com/
Cybersecurity rating
Sectors

Key People

  • Mahima Datla

    Mahima Datla, MD & CEO, Vaccines & Branded Formulations

  • Lakshminarayana Neti

    Lakshminarayana Neti, COO, Vaccines & Branded Formulations

  • Narender Dev Mantena

    Narender Dev Mantena, Head, Global Strategy & CEO, Specialty Generic Injectables & Synthetic Biology

  • Madhusudan Rao

    Madhusudan Rao, COO, Specialty Generic Injectables

Operating MetricsView all

Vaccines Produced, doses

483M
6.9%

FY, 2019

Vaccines Sold, doses

305M
6.2%

FY, 2019

Suppliers

1.6K
1.8%

FY, 2019

LocationsView all

5 locations detected

  • Hyderabad, TG HQ

    India

    Rd Number 35, Aditya Enclave, Venkatagiri, Jubilee Hills

  • Cary, NC

    United States

    203 New Edition Ct

  • Hyderabad, TG

    India

    18/1&3, Azamabad, Bharat Nagar

  • Kolthur, TG

    India

    Plot No. 1, Biotech Park, Phase II, Kolthur Village

  • Zug, ZG

    Switzerland

    Rothusmatt 3

Biological E Financials

Summary Financials

Revenue (FY, 2019)
₹9.3B

Footer menu